FDA Import Refusal 799-0584378-6/11/1 — NOVO NORDISK PHARMA AG
The FDA refused shipment 799-0584378-6/11/1 from NOVO NORDISK PHARMA AG (Switzerland) on May 8, 2024. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- May 8, 2024
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 61PCK17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75